Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,116
Recruiting: 10,894
Ph III recruiting: 1,280
Growth YoY: +12%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,163)

clinicaltrialsPublishedShowing 2,251–2,300 of 2,679 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06987916	Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma	recruiting	Phase 1 / Phase 2	50	Shanghai Tongji Hospital, Tongji University School of MedicineOTHER	1	Jun 5, 2025	clinicaltrials
NCT06816823	CAR-NK Cells (CL-NK-001) in Pancreatic Cancer	recruiting	Phase 1	30	Changhai HospitalOTHER	1	Jun 4, 2025	clinicaltrials